focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.50 (1.12%)
Spread: 2.00 (4.545%)
Open: 44.50
High: 45.00
Low: 44.50
Prev. Close: 44.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Cognition revenue climbs despite swing to annual loss

Wed, 03rd May 2023 17:21

(Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it had a "transformative" 2022, as revenue climbed 25% against the previous year.

The Cambridge, England-based digital health products technology developer said revenue in 2022 rose to GBP12.6 million, up 25% from GBP10.1 million a year earlier. Services revenue grew by 16% in 2022 to GBP6.5 million, whilst Software revenue climbed 39% to GBP5.0 million.

However, the company swung to a pretax loss of GBP600,000 from a pretax profit of GBP300,000 year-on-year. It also swung to a loss per share of 1.3 pence, from an earnings per share of 1.4 pence.

The financial results for the year were tempered by a slightly slower-than-expected final quarter, as the company experienced delays and scope reduction associated with large orders, Cambridge Cognition explained. It added that market forecasts suggest that this is not representative of a long-term trend.

The company ended 2022 with a contracted order book of GBP17.6 million, which increased further to GBP19.1 million in January, following the acquisition of Winterlight Labs.

Cambridge Cognition bought Winterlight Labs for GBP7.0 million back in January.

Looking ahead, Cambridge Cognition said that its strong contracted order book provides "excellent" revenue visibility through 2023.

"2022 was a transformational year for Cambridge Cognition, marked by significant multi-year orders, sustained revenue growth, and the expansion of our core product set," said Chief Executive Officer Matthew Stork.

"Looking ahead, we remain committed to our objectives of driving revenue and profit growth by increasing our market share through offering the most innovative technology, supported by outstanding scientific evidence and a very experienced team, in the high-value market for CNS drug development."

Shares in Cambridge Cognition closed down 4.6% to 93.00 pence each.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
22 Jun 2016 09:50

Cambridge Cognition signs distribution deal with Manus Neurodynamica

(ShareCast News) - AIM-listed neuroscience technology company Cambridge Cognition Holdings has signed a distribution agreement to market a Parkinson's sensor pen for healthcare technology group Manus Neurodynamica. Manus' sensor pen is used for the diagnosis and monitoring of neuromotor impairments

Read more
22 Jun 2016 06:24

Cambridge Cognition Inks Distribution Deal With MANUS Neurodynamica

Read more
16 Jun 2016 15:12

UK Shareholder Meetings Calendar - Next 7 Days

Read more
2 Jun 2016 07:26

Cambridge Cognition Strikes Reseller Agreement With AnthroTronix

Read more
6 May 2016 08:43

DIRECTOR DEALINGS: Cambridge Cognition CEO Buys 30,000 Shares

Read more
5 May 2016 08:30

Cambridge Cognition Submits CANTAB Mobile For US Clearance

Read more
25 Apr 2016 14:23

DIRECTOR DEALINGS: Three Cambridge Cognition Directors Subscribe

Read more
25 Apr 2016 06:42

Cambridge Cognition Raises GBP1.3 Million As Annual Loss Widens (ALLISS)

Read more
11 Apr 2016 09:30

Cambridge Cognition Launches Trial Recruitment Portal CANTAB Recruit

Read more
4 Apr 2016 14:07

Cambridge Cognition to unveil new software prototype

(ShareCast News) - Cambridge Cognition was preparing to show off its latest wares on Monday, announcing it was to present the first prototype of a ground-breaking new software application to improve the understanding, diagnosis and treatment of mental health, in conjunction with Ctrl Group. The AIM-

Read more
16 Mar 2016 10:33

WINNERS & LOSERS SUMMARY: Forbidden Technologies Up On Microsoft Deal

Read more
16 Mar 2016 09:46

Cambridge Cognition Expects To Post GBP800,000 Loss For 2015

Read more
1 Mar 2016 14:37

Cambridge Cognition announces wearable tech partnership

(ShareCast News) - Cambridge Cognition was reaching out to a new frontier in the world of wearable technology on Tuesday, announcing a new partnership with London-based design and research agency Ctrl Group for the creation of products for use in mental health applications. The AIM-traded company, w

Read more
1 Mar 2016 09:49

Cambridge Cognition Signs Wearables Partnership With Ctrl Group

Read more
15 Feb 2016 09:01

Cambridge Cognition Makes Interim CEO Powell Permanent Boss

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.